Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis C virus nonstructural protein 3 (NS3) is a multifunctional viral protein essential for the life cycle of the hepatitis C virus (HCV). It is produced as a 70 kDa cleavage product from the HCV polyprotein and plays critical roles in viral replication, polyprotein processing, and immune evasion. It contains a N-terminal serine protease domain responsible for cleaving the nonstructural region of the HCV polyprotein and a C-terminal helicase/NTPase domain, which functions as an RNA helicase and nucleoside triphosphatase, unwinding RNA during genome replication and assembly. NS3 requires association with its cofactor, nonstructural protein 4A (NS4A), to achieve full enzymatic activity. Several direct acting antivirals—such as boceprevir, telaprevir, paritaprevir—specifically inhibit NS3/4A protease activity.
Inhibition of NS3/4A protease activity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C Virus Nonstructural Protein 3 (NS3).